Basic HTML-Version
31
Projects 2010/2011:
Acronym Full title
Partners
HIPH Staff
*doctoral
students
Funding
agency and
timeline
Main results and outlook
D4
Efficacy, safety
and public health
aspects of ITNs
in Africa
HIPH; CRSN; Ministry of Health
Burkina Faso
Olaf Müller
Albrecht Jahn
Manuela De
Allegri
Valérie Louis
Joelle Bals*
Maike Tipke*
Tabea Schroer*
DFG
SFB 544
(1999-2011)
ITNs are safe in all age groups and in all
endemic areas; compliance remains a
challenge during the hot and dry season
in West Africa; universal coverage is the
best public health strategy; replacement
sytems for old ITNs remain a challenge
A8
Development of
methylene blue
(MB) -based ma-
laria treatment
combination
therapy
HIPH; Institute for Biometrics
and Informatics, Heidelberg;
University of Düsseldorf;
University of Ulm; CRSN;
Centre National de Recherche
et de Formation sur le Paludis-
me (CNRFP)
Olaf Müller
Bernd Marks
Maike Tipke*
DFG
(SFB 544)
(2005-2011)
MB is safe and effective in African
malaria patients; it acts slow against the
parasites and thus needs to be com-
bined with appropriate partner drugs;
it is currently the most effective drug
against the gametocytes of P. falcipa-
rum; adding MB to existing ACTs could
be a good strategy
GK 793 Malnutrition in
young children of
Burkina Faso
CRSN
Olaf Müller
Claudia Beiers-
mann*
DFG
(2008-2011)
Malnutrition has only marginally decli-
ned in rural Burkina Faso over the past
decades and remains a major neglected
area in international public health
Optimu-
nise
Unspecific ef-
fects of child-
hood immun-
isations in SSA
HIPH; States Serum Institute,
Denmark LSHTM, UK; CRSN
Burkina Faso, Navrongo
Heiko Becher
Olaf Müller
Nobila Oued-
raogo*
EU
(2011-2015)
The project aims to analyse routine data
from three DSS sites in SSA; in addition
it aims at conducting a RCT on an al-
ternative measles vaccine regimen.
AIDS in
Malawi
AIDS in Malawi
HIPH; Light house, Malawi
Florian Neu-
hann, Heribert
Ramroth, Flo-
rian Scheibe*,
Julia Lübbert*
Hector Foun-
dation
(2008-2014)
Treatment interruption of ART is associa-
ted with restistance development in
25 % of cases.
Dengue-
Tools
Strategies and
tools for the
surveillance and
control of dengue
University of Umeå, Sweden;
LSHTM; University of Singapore;
University of Malaysia; Ministry
of Health, Sri Lanka; University of
Sao Paolo; Mahidol University,
Thailand; TwistDx, Cambridge;
Oxitec, Oxford; Institute
Pasteur, Paris; Swiss Tropical
Institute, Basel
Valérie Louis
Yesim Tozan
Annelies
Wilder-Smith
EU FP7
(2011-2015)
To develop novel tools and strategies to
control dengue